Neutralisation of SARS-CoV-2 Omicron subvariants BA.2.86 and EG.5.1 by antibodies induced by earlier infection or vaccination
Ria Lassaunière(Statens Serum Institut), Morten Rasmussen, Marc Stegger(Statens Serum Institut), Sharmin Baig(Statens Serum Institut), Pikka Jokelainen(Statens Serum Institut), Delphine Planas(Centre Hospitalier de l’Université de Montréal), Kirsten Ellegaard(Statens Serum Institut), Olivier Schwartz(Centre National de la Recherche Scientifique), Etienne Simon‐Lorière(Institut Pasteur), Tyra Grove Krause(Statens Serum Institut), Leandro Andrés Escobar-Herrera, Charlotta Polacek(Statens Serum Institut), Katja Spieß(University of Copenhagen), Anders Fomsgaard(Statens Serum Institut), Raphael N. Sieber(Statens Serum Institut), Uffe Vest Schneider(Statens Serum Institut), Henrik Ullum(Statens Serum Institut)
Cited by 4
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Syncytia formation by SARS‐CoV‐2‐infected cells
|The EMBO Journal|2020|497
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecALGA251
|Clinical Microbiology and Infection|2011|429